Literature DB >> 8033425

Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia.

A Gabrielli1, A Manzin, M Candela, M L Caniglia, S Paolucci, M G Danieli, M Clementi.   

Abstract

The presence of hepatitis C virus (HCV) genomic sequences was checked in plasma, liver, peripheral blood mononuclear cells (PBMC) and bone marrow cells from 11 patients with mixed cryoglobulinaemia positive for anti-HCV antibodies, and from 11 patients with chronic HCV hepatitis without serological evidence of cryoglobulinaemia. HCV RNA sequences were demonstrated by reverse transcription polymerase chain reaction in seven plasma samples, in six PBMC samples, and in seven bone marrow cell samples from the 11 cryoglobulinaemic subjects; otherwise, viral specific nucleic acids were detected in 10 plasma samples, in one PBMC sample, and in two bone marrow cell samples from the 11 patients with chronic hepatitis. The HCV replicative intermediate was evidenced in four of the six PBMC and in five of the seven bone marrow aspirate HCV RNA-positive samples. Analysis of subpopulations isolated from bone marrow and peripheral blood samples showed HCV RNA sequences in mononuclear cells belonging either the CD2+ subset or to the CD19+ subpopulation or to the adherent cells. Finally, we compared the nucleotide sequences of a large portion (-270 to -59) of the HCV 5'-untranslated region from five patients with mixed cryoglobulinaemia and from seven patients with chronic hepatitis without cryoglobulinaemia; the degree of heterogeneity, compared with the prototype HCV sequence, was similar in both groups. These findings from two groups of HCV-infected patients indicate that transient or permanent active HCV infection of bone marrow and PBMC is frequent in anti-HCV-positive patients with mixed cryoglobulinaemia, and suggest that extra-hepatic infection may play a major role in influencing the pathophysiology of this infection as well as the viral persistence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033425      PMCID: PMC1534776          DOI: 10.1111/j.1365-2249.1994.tb06584.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin.

Authors:  J LOSPALLUTO; B DORWARD; W MILLER; M ZIFF
Journal:  Am J Med       Date:  1962-01       Impact factor: 4.965

2.  Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis.

Authors:  M Farivar; J R Wands; G D Benson; J L Dienstag; K J Isselbacher
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

3.  Liver involvement in the syndrome of mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; H Tobias; E C Franklin
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

4.  Association between hepatitis B virus and essential mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; D Zucker-Franklin; E C Franklin
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

5.  Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.

Authors:  G Fiorini; P Bernasconi; R A Sinico; R Chianese; F Pozzi; G D'Amico
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

8.  Liver involvement in essential mixed cryoglobulinemia.

Authors:  S Bombardieri; C Ferri; O Di Munno; G Pasero
Journal:  Ric Clin Lab       Date:  1979 Oct-Dec

9.  Evidence of immune deposits and of basement membrane alterations in dermal vessels of normal skin of patients with essential mixed cryoglobulinemia.

Authors:  A Gabrielli; A Sbarbati; G Marchegiani; S Rupoli; M Montroni; S Cinti; G Danieli
Journal:  Arthritis Rheum       Date:  1987-08

Review 10.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  12 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; el-Rashdy M Redwan; Samar Youssef; Moataza H Omran; Fouad Thakeb; Maha el-Demellawy
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 3.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Authors:  Ariane Larouche; Geneviève Gaëtan; Nabil El-Bilali; Mathieu Quesnel-Vallières; Steven R Martin; Fernando Alvarez; Naglaa H Shoukry; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

5.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

6.  Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity.

Authors:  L Cook; A M Ross; G B Knight; V Agnello
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  HCV infection in a patient with hyper IgM syndrome.

Authors:  I Quinti; A Giovannetti; R Paganelli; L P Pucillo; A R Varani; G Ricci; E Scala; F Pandolfi; M Casato; F Aiuti
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

8.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

9.  Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.

Authors:  D Sansonno; A R Iacobelli; V Cornacchiulo; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

Review 10.  Extrahepatic cancers and chronic HCV infection.

Authors:  Stanislas Pol; Anaïs Vallet-Pichard; Olivier Hermine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-17       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.